Kura Oncology KURA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's operating income?
- Kura Oncology (KURA) reported operating income of -$78.82M in Q1 2026.
- How has Kura Oncology's operating income changed year-over-year?
- Kura Oncology's operating income decreased by 21.8% year-over-year, from -$64.7M to -$78.82M.
- What is the long-term trend for Kura Oncology's operating income?
- Over 3 years (2022 to 2025), Kura Oncology's operating income has grown at a 29.5% compound annual growth rate (CAGR), from -$139.87M to -$303.63M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.